Great Valley Advisor Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.47M | Buy |
12,332
+139
| +1% | +$47.6K | 0.07% | 245 |
|
|
2026
Q1 | $4.29M | Buy |
12,193
+1,049
| +9% | +$374K | 0.08% | 224 |
|
|
2025
Q4 | $3.65M | Buy |
11,144
+190
| +2% | +$60.3K | 0.07% | 239 |
|
|
2025
Q3 | $3.09M | Buy |
10,954
+1,303
| +14% | +$378K | 0.06% | 252 |
|
|
2025
Q2 | $2.7M | Sell |
9,651
-494
| -5% | -$140K | 0.06% | 261 |
|
|
2025
Q1 | $3.16M | Sell |
10,145
-9,206
| -48% | -$2.72M | 0.07% | 242 |
|
|
2024
Q4 | $5.04M | Buy |
19,351
+1,443
| +8% | +$428K | 0.11% | 170 |
|
|
2024
Q3 | $5.77M | Buy |
17,908
+10,136
| +130% | +$3.32M | 0.14% | 155 |
|
|
2024
Q2 | $2.43M | Buy |
7,772
+686
| +10% | +$202K | 0.07% | 261 |
|
|
2024
Q1 | $2.01M | Buy |
7,086
+71
| +1% | +$20.8K | 0.06% | 275 |
|
|
2023
Q4 | $2.02M | Buy |
7,015
+155
| +2% | +$42.2K | 0.07% | 238 |
|
|
2023
Q3 | $1.84M | Sell |
6,860
-284
| -4% | -$70.9K | 0.08% | 228 |
|
|
2023
Q2 | $1.59M | Sell |
7,144
-554
| -7% | -$129K | 0.07% | 249 |
|
|
2023
Q1 | $1.86M | Buy |
7,698
+1,020
| +15% | +$250K | 0.09% | 219 |
|
|
2022
Q4 | $1.75M | Sell |
6,678
-150
| -2% | -$40.2K | 0.09% | 233 |
|
|
2022
Q3 | $1.54M | Sell |
6,828
-112
| -2% | -$27.1K | 0.09% | 228 |
|
|
2022
Q2 | $1.69M | Buy |
6,940
+580
| +9% | +$142K | 0.09% | 216 |
|
|
2022
Q1 | $1.52M | Sell |
6,360
-17
| -0.3% | -$3.91K | 0.09% | 228 |
|
|
2021
Q4 | $1.43M | Sell |
6,377
-371
| -5% | -$78.3K | 0.09% | 224 |
|
|
2021
Q3 | $1.44M | Buy |
6,748
+76
| +1% | +$17.5K | 0.1% | 207 |
|
|
2021
Q2 | $1.63M | Buy |
6,672
+31
| +0.5% | +$7.63K | 0.12% | 186 |
|
|
2021
Q1 | $1.65M | Sell |
6,641
-116
| -2% | -$27.7K | 0.16% | 145 |
|
|
2020
Q4 | $1.55M | Buy |
6,757
+359
| +6% | +$82.8K | 0.16% | 141 |
|
|
2020
Q3 | $1.63M | Buy |
6,398
+115
| +2% | +$28.5K | 0.2% | 109 |
|
|
2020
Q2 | $1.48M | Buy |
6,283
+596
| +10% | +$136K | 0.24% | 114 |
|
|
2020
Q1 | $1.15M | Sell |
5,687
-43
| -0.8% | -$9.39K | 0.31% | 102 |
|
|
2019
Q4 | $1.38M | Buy |
5,730
+52
| +0.9% | +$11.5K | 0.31% | 97 |
|
|
2019
Q3 | $1.1M | Buy |
5,678
+3
| +0.1% | +$576 | 0.27% | 113 |
|
|
2019
Q2 | $1.05M | Sell |
5,675
-266
| -4% | -$47.6K | 0.26% | 122 |
|
|
2019
Q1 | $1.13M | Buy |
5,941
+97
| +2% | +$18.5K | 0.36% | 79 |
|
|
2018
Q4 | $1.14M | Buy |
+5,844
| New | +$1.14M | 0.43% | 61 |
|
Other funds holding AMGN
Great Valley Advisor Group's AMGN Position: Q2 2026 in Review
Great Valley Advisor Group increased its Amgen (AMGN) stake by 1.1% in Q2 2026, buying an estimated $47.6K and bringing the position to 12,332 shares worth $4.47M. The position accounts for 0.07% of the portfolio, ranked #245.
Great Valley Advisor Group first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.77M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Great Valley Advisor Group held 12,332 shares of Amgen worth $4.47M as of Q2 2026.
- Great Valley Advisor Group bought 139 Amgen shares in Q2 2026, an estimated $47.6K.
- Amgen made up 0.07% of Great Valley Advisor Group's portfolio in Q2 2026, its #245 holding.
- Great Valley Advisor Group first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- Great Valley Advisor Group's Amgen position peaked at $5.77M in Q3 2024.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.